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Introduction
Increased ligand binding affinity of integrins (“activation”) is 
central to cell migration, extracellular matrix assembly, immune 
response, and hemostasis (Hynes, 2002). There remain un-
certainties about the final events that lead to activation, including 
whether talin binding to the integrin is sufficient for activation 
(Moser et al., 2009b), whether conformational changes lead to 
activation (Bazzoni and Hemler, 1998; Carman and Springer, 
2003), the nature of such conformational changes (Takagi et al., 
2002; Adair et al., 2005), and the role of mechanical force (Zhu 
et al., 2008). A critical barrier to answering these questions is 
the absence of systems that enable a complete recreation of the 
final steps in physiological integrin activation.
Integrins are noncovalent heterodimers of transmembrane 
- and -subunit, each with a single transmembrane and cyto-
plasmic domain (tail; Hynes, 2002); activation is initiated through 
interactions at the integrin tails (O’Toole et al., 1991, 1994). 
Both in vitro (Calderwood et al., 1999; Tadokoro et al., 2003) and 
in vivo (Nieswandt et al., 2007; Petrich et al., 2007a,b) studies 
reveal that the binding of the 50-kD talin head domain (THD) 
to the integrin- tail is involved in integrin activation. Recent 
in vitro (Ma et al., 2008) and in vivo experiments (Montanez 
et al., 2008; Moser et al., 2008, 2009a) indicate that kindlins 
are important in integrin activation. Kindlins bind integrin- 
tails (Kloeker et al., 2004) and this interaction is involved in 
activation (Shi et al., 2007; Ma et al., 2008; Moser et al., 2008), 
suggesting that talin requires kindlins to activate integrins (Moser 
et al., 2009b). The forgoing experiments used genetic modifica-
tions or expression of recombinant proteins in cells; such studies 
are subject to potential contributions of unknown cellular com-
ponents and of complex effects of deletion or overexpression 
of proteins. Indeed, kindlin-3 deletion induces dramatic global 
changes in cytoskeletal composition (Krüger et al., 2008) and 
talin can regulate the biosynthesis of PIP2, a critical regulator of 
the cytoskeleton (Di Paolo et al., 2002). In consequence, a defin-
itive test of the sufficiency of talin for integrin activation requires 
a means to analyze the activation of purified integrins.
Increased affinity of integrins for the extracellular ma-trix (activation) regulates cell adhesion and migration, extracellular matrix assembly, and mechanotransduc-
tion. Major uncertainties concern the sufficiency of talin 
for activation, whether conformational change without 
clustering leads to activation, and whether mechanical 
force is required for molecular extension. Here, we re-
constructed physiological integrin activation in vitro and 
used cellular, biochemical, biophysical, and ultrastructural 
analyses to show that talin binding is sufficient to activate 
integrin IIb3. Furthermore, we synthesized nanodiscs, 
each bearing a single lipid-embedded integrin, and used 
them to show that talin activates unclustered integrins 
leading to molecular extension in the absence of force or 
other membrane proteins. Thus, we provide the first proof 
that talin binding is sufficient to activate and extend 
membrane-embedded integrin IIb3, thereby resolving 
numerous controversies and enabling molecular analysis 
of reconstructed integrin signaling.
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of the liposomes (Fig. 2 B) and quantification revealed an 
approximate 2:1 molar ratio of THD to integrin in the lipo-
somes. No gross integrin clustering was observed either in the 
presence or absence of THD (Fig. 1, A and B).
Having confirmed the coincorporation of THD and inte-
grin IIb3 in liposomes, we next sought to test if the THD 
activated the purified integrins by measuring the binding of 
an activation-specific antibody, PAC1 (Shattil et al., 1985). 
Incorporation of THD into the liposomes increased PAC1 binding 
(Fig. 2 A) as judged by flow cytometry. Importantly, the increase 
in PAC1 binding was not due to altered IIb3 content of the 
liposomes (Fig. 2, B and C), or increased liposome size or aggre-
gation as judged by forward scatter (Fig. 2, B and C). Binding 
was specific, as it was blocked by a competitive antagonist, epti-
fibatide (Scarborough et al., 1993). We calculated an “activation 
index” (100 × (F  F0) / (Fmax  F0), where F = PAC1 binding, 
F0 = binding in the presence of 1 µM eptifibatide, and Fmax = 
binding in the presence of 1 mM MnCl2) and found that incor-
poration of THD resulted in a twofold increase in PAC1 binding 
(40% vs. 20% in the absence of THD). Furthermore, THD 
did not change the orientation of IIb3 in the liposomes (Fig. 2, 
A and B). Thus, THD is sufficient to activate purified integrin 
IIb3 in vitro.
THD activates an integrin mutant that is 
defective in kindlin binding
To see whether THD binding is sufficient to activate IIb3 in 
vivo, we examined the effect of THD on integrins bearing 3 
subunit mutations that selectively block talin or kindlin binding. 
The 3(Y747A) mutant impairs talin but not kindlin binding, 
whereas the 3(Y759A) mutant retains the ability to bind to 
talin but is defective in kindlin binding (Ma et al., 2008; Moser 
et al., 2008). We created CHO cells that stably express IIb3, 
IIb3(Y759A), or IIb3(Y747A). Expression of THD acti-
vated IIb3 but not IIb3(Y747A) (Fig. 2 D). Consistent 
with our finding that THD is sufficient for integrin activation, 
THD activated IIb3(Y759A) (Fig. 2 D). Kindlin-3 does not 
activate IIb3 in CHO cells (Moser et al., 2008) or synergize 
with THD (unpublished data). We therefore examined the effect 
of the Y759A mutation on the capacity of kindlin-2 (Ma et al., 2008) 
to synergize with THD in CHO cells. THD and kindlin-2 synergized 
in activating IIb3 but not IIb3(Y759A) (Fig. 2 D), indicating 
that the mutant did indeed perturb the functional consequences 
of kindlin binding. Importantly, the expression levels of THD 
and kindlin-2 were comparable in IIb3-, IIb3(Y747A)-, and 
IIb3(Y759A)-expressing cells (Fig. 2 D). Thus, both in vitro 
and in vivo, THD binding activates integrin IIb3 independent 
of kindlin binding.
THD activates IIb3 by binding the 3 tail
Talin activates IIb3 by binding to the 3 tail (García-Alvarez 
et al., 2003; Wegener et al., 2007) in cells. We sought to as-
certain whether THD activated purified IIb3 by binding to 
the 3 tail. We first examined the capacity of added THD to ac-
tivate IIb3 in intact cells and found no effect on PAC1 bind-
ing at concentrations up to 25 µM. Second, we found that 
THD(W359A), a mutant with reduced affinity for the 3 tail 
Integrins exist in at least three functional states: inactive, 
active, and active and ligand-occupied (Frelinger et al., 1991), 
and long-range allosteric rearrangements underlie the transi-
tions between these states (Du et al., 1993). The landmark struc-
ture of integrin V3 ectodomain revealed a bent conformation 
(Xiong et al., 2001). An electron microscopy (EM) study pro-
posed that activation required the bent integrin to assume an 
extended conformation (Takagi et al., 2002); however, another 
analysis revealed that the bent form could bind ligand and 
ascribed the earlier results to sampling bias (Adair et al., 2005). 
A recent structure of the integrin IIb3 ectodomain was bent, 
suggesting that extension required tractional forces or collisions 
with other membrane proteins (Zhu et al., 2008). These studies 
used soluble integrins, lacking the transmembrane and cyto-
plasmic domains that regulate affinity state (Ginsberg et al., 
2005). Studies on full-length integrins have been limited by a 
number of factors and have led to divergent results (Hantgan 
et al., 2001; Adair and Yeager, 2002; Iwasaki et al., 2005). 
Cryo-EM of lipid bilayer-embedded integrin IIb3 (Ye et al., 
2008) revealed an 11-nm height, consistent with the bent form; 
the height did not change in response to Mn++ activation, which 
alters the cation coordination in integrin A domains (Shimaoka 
et al., 2002). Furthermore, integrin clustering is linked to inte-
grin activation (Li et al., 2003) and the relative contribution of 
clustering and conformational changes is hotly debated (Bazzoni 
and Hemler, 1998; Carman and Springer, 2003).
Here, we recreated the triggering event in physiological 
activation of integrin IIb3 and performed cellular, biochemi-
cal, biophysical, and EM analyses. We find that THD binding to 
the integrin- tail is sufficient for activation; however, efficient 
talin-induced activation requires embedding of the integrin in a 
phospholipid bilayer and a membrane-binding site on the talin. 
We used phospholipid nanodiscs to create lipid-embedded inte-
grins in which simultaneous access to the extracellular and cyto-
plasmic domain is available and in which the unclustered state 
is enforced. Using these nanodiscs, we show that THD binding 
activates single monomeric integrins and that talin binding 
alone, in the absence of force or of other membrane proteins, is 
sufficient to induce the extended conformation. Thus, we pro-
vide the first proof that talin binding is sufficient to activate and 
extend membrane-embedded integrin IIb3.
Results
THD activates purified integrin IIb3
Expression of THD in cells activates integrins (Calderwood 
et al., 1999; Tadokoro et al., 2003); however, talin may not be 
sufficient because a kindlin is required for activation (Moser 
et al., 2009b). To ascertain whether THD is sufficient to activate 
integrin IIb3, we reconstituted the highly purified integrin 
into phospholipid vesicles with or without THD (Fig. 1, A and B). 
The individual integrins inserted into the lipid bilayer were 
clearly visible, indicating successful integrin incorporation. The 
integrins were randomly oriented (35–50% were facing the out-
side) as judged by cryo-EM tomograms (Fig. 1, A and B). THD 
is too small to be visualized in the tomograms; however, we 
verified the coincorporation of THD and integrins by SDS-PAGE 
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Nevertheless, the levels of integrin and incorporated THD were 
similar in the liposomes formed with calpain-cleaved IIb3 or 
intact IIb3 (Fig. 3 E). Thus, activation required an intact 3 
tail and THD access to and capacity to bind the 3 tail. We 
therefore conclude that in a purified system, THD is sufficient to 
activate IIb3 by binding to the 3 tail.
The importance of lipids for THD activation
THD(K322D) fails to activate IIb3 (Wegener et al., 2007) in 
cells; K322 is predicted to interact with phospholipid head 
groups rather than the 3 tail, an interaction proposed to orient 
the talin to favor activation (Fig. 4 A). To verify this contact with 
lipids, we tested the interaction of purified F3 or F3(K322D) 
with liposomes using a cosedimentation assay. The K322D mu-
tation impaired F3 cosedimentation with lipid, thus providing 
direct evidence that the mutation impairs lipid binding (Fig. 4 D). 
Moreover, as predicted (Wegener et al., 2007), THD(K322D) 
binds to the 3 tail (Fig. S1). Purified recombinant THD(K322D) 
failed to activate IIb3 in liposomes (Fig. 4, B and C) even 
(García-Alvarez et al., 2003), failed to activate the purified 
integrin (Fig. 3, A and B). The sharp melting point of 
THD(W359A) indicated that the protein was well folded, al-
though the 1.7° lower melting point suggests it was slightly less 
stable than wild-type THD. (Fig. 3 F). In addition, THD(W359A) 
was incorporated into the liposomes (Fig. 3 A). Thus, THD 
required both access to the 3 tail and the capacity to bind to it 
in order to activate IIb in vitro.
As a further test of the mechanism of THD-induced acti-
vation, we assessed the requirement for the 3 tail. Mild calpain 
digestion selectively cleaves the 3 tail from purified IIb3 
(Du et al., 1995); calpain removed the 3 C terminus as judged 
by an anti-peptide antibody directed against this region 
(Du et al., 1995), but did not influence the binding of an antibody 
raised against full-length 3 (Fig. 3 C). Furthermore, this mild 
cleavage, which removes <5% of the mass of 3, produced no 
detectable change in the mobility of IIb or 3 in SDS-PAGE 
(Fig. 3 C) and did not remove the C terminus of IIb (Fig. 3 C). 
THD failed to activate the calpain-cleaved integrin (Fig. 3 D). 
Figure 1. Cryo-EM tomography reveals insertion of unclustered integrins into liposomes. (A) Central section of the cryo-EM tomogram of frozen hydrated 
liposomes with integrin IIb3 and THD co-incorporated. (B) Central section of the cryo-EM tomogram of liposomes containing only integrin IIb3. The 
individual integrins were clearly visible in both A and B with a head density connected by a narrow leg density to the lipid densities, indicating that the 
integrins were incorporated into the lipid bilayers. Insets show magnified views of a few regions in both A and B and indicate that the integrins are well 
resolved. No gross clustering was observed in the presence or absence of THD. The red arrows point to the individual integrin densities.
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To ascertain if lipid-inserted integrins were required for 
THD-induced activation, we assessed the effect of THD on pu-
rified detergent-solubilized IIb3. We first captured detergent-
solubilized IIb3 with an anti-3 antibody and assayed its 
activation state by PAC1 binding (Fig. 4 E, left; Du et al., 1991). 
THD failed to increase PAC1 binding to detergent-solubilized 
IIb3 at concentrations approaching a 1,000-fold molar excess 
though it was well folded (Fig. 3 F) and incorporated into the 
liposomes (Fig. 4 B). A previously proposed model (Wegener 
et al., 2007) suggested that the precise physical relationship of 
F3 relative to the integrin and the membrane controls activation. 
The present study shows that K322D mutation affects lipid 
binding and that it disrupts activation in a purified system even 
though the THD is well folded and binds the integrin.
Figure 2. Talin binding is sufficient to activate integrins. (A) Liposome size vs. PAC1 binding. Flow cytometric data were analyzed in 11 regions of for-
ward scatter (FSC; a measure of particle size). THD increased PAC1 binding () compared with integrin alone () or empty liposomes (). (B) Activation 
indices plotted against liposome size. The presence of THD () increased activation relative to its absence (). The inset depicts an SDS-PAGE of integrin 
liposomes in the presence and absence of THD. Data in A and B are from one of three independent experiments. (C) Activation indices of the liposomes at 
the mid-point of the forward scatter spectrum (mean FSC = 142) were averaged from three experiments. THD increased integrin activation. Unless other-
wise indicated, error bars in the graphs shown here and below denote the standard error of three independent experiments. (D) THD activates an integrin 
mutant defective in kindlin binding. THD activated integrin IIb3, and coexpression of kindlin-2 led to an additional increase in activation. In contrast, THD 
activated IIb3(Y759A), a mutant defective in kindlin binding, whereas kindlin-2 did not augment the activation. IIb3(Y747A), which is defective in 
talin binding, was not activated by THD nor by a combination of THD and kindlin 2. Activation index is calculated as in B. The bottom panel is a Western 
blot showing that the expression of THD and kindlin-2 are comparable in IIb3, IIb3(Y759A), or IIb3(Y747A) cells.
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Figure 3. THD activates purified IIb3 by binding to the 3 tail. (A) THD induced an increase in PAC1 binding (), whereas THD-W359A (), a mutant 
deficient in integrin tail binding, failed to do so. The inset on the right depicts SDS-PAGE showing that integrin and THD are comparable. Data are from one 
of three independent experiments. (B) Activation indices of the subset of liposomes at the mid-point of the forward scatter spectrum (mean FSC = 142) were 
averaged over three independent experiments. Increases in integrin activation (calculated as AIwith_THD  AIintegrin_alone, where AI stands for activation indices) 
are depicted. THD increased integrin activation compared with THD-W359A. (C) Requirement of the 3 tail for THD activation. Using the ELISA described 
in the Materials and methods section, calpain abolished anti–3-c tail binding but had no effect on anti-3 or anti–IIb-c tail binding. SDS-PAGE revealed 
that calpain did not markedly shift mobility of 3 or IIb. (D) THD fails to activate IIb3 lacking the 3 C terminus. Increase in integrin activation was 
calculated as in B. (E) SDS-PAGE shows that integrin and THD incorporation are comparable for calpain-digested and intact integrins. (F) THD mutants do 
not disrupt protein folding. Differential scanning calorimetry of THD, THD-W359A, and THDF-K322D. All three proteins exhibited similar narrowly defined 
melting points, indicating that they were well folded.
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dramatic increase (Fig. 4 G). These results are in sharp contrast 
to those in the reconstituted liposomes wherein activation is 
observed at a 2:1 molar ratio of THD to IIb3 (Fig. 2 B). Thus, 
efficient THD-induced IIb3 integrin activation requires that 
the integrin be inserted into a lipid bilayer.
Talin activates unclustered integrins
Having established THD is sufficient to activate membrane-
embedded integrin IIb3 by binding to the 3 tail, we exam-
ined the relative role of increased monomer affinity. As noted 
to the integrin (Fig. 4 F). THD binds to IIb3 with an affinity 
of Kd 400 nM (Goldmann, 2000), and we saw no effect of 
THD at concentrations almost 2 logs higher than this Kd. The 
assay was functioning because addition of 1 mM MnCl2 induced 
a marked increase in PAC1 binding that was blocked by epti-
fibatide (Fig. 4 F, right). We also developed an alternative assay 
format in which the detergent-solubilized IIb3 was mixed 
with THD in solution and activation was measured by capture 
with immobilized PAC1 (Fig. 4 E, right). Again, THD failed to 
promote IIb3 binding to PAC1, whereas Mn2+ resulted in a 
Figure 4. The importance of lipid embedding for THD activation. (A) A model of talin head–integrin-3 tail interaction (Wegener et al., 2007). 3 tail is 
shown in ribbon diagram and the F3 domain of talin is shown in solid surface. The two mutations, W359A (blocks integrin binding) and K322D (predicted to 
reduce membrane binding), are highlighted in blue and red, respectively. (B) THD-K322D () caused markedly reduced PAC1 binding relative to THD (). 
Data are from one of three independent experiments. The SDS-PAGE on the right confirms that the integrin and THD incorporation are comparable for 
THD-K322D and THD (both lanes were excised from the same gel image and were juxtaposed for clarity). (C) Activation indices of the subset of liposomes 
at the mid-point of the forward scatter spectrum were averaged over three independent experiments. Increases in integrin activation were calculated as in 
Fig. 3 B. THD but not THD-K322D induced increased integrin activation. (D) The K322D mutation reduces F3–membrane interaction. Co-sedimentation of 
F3 or F3-K322D with liposomes was assessed by SDS-PAGE. Densitometry was used to quantify these results, which are depicted in the bar graph to the 
right. Mass spectrometry revealed that both F3-WT and F3-K322D were within 0.1% of their predicted masses; hence, the increased mobility of F3-K322D 
is ascribed to its increased negative charge. (E) Schematic of assays for measuring activation of detergent-solubilized IIb3. (F) THD failed to activate 
captured detergent-solubilized integrin. IIb3 was mixed with various concentrations of THD and was captured on a plate coated with AP3, and activated 
IIb3 was detected by PAC1 binding. Captured IIb3 was detected by the binding of polyclonal anti-3 antibody (anti-3). PAC1 binding was low and 
did not change even with 1,000-fold molar excess of THD. The panel on the right shows that Mn++ activated the IIb3 in the same experiment. (G) The 
plate was coated with PAC1 and IIb3 mixed with various concentrations of THD was then added to the plate. The bound integrins were detected with 
polyclonal anti-3 antibody. At a 1,000-fold molar excess, THD failed to induce binding of PAC1 to the IIb3; in contrast, 1 mM Mn++ did so, and the 
binding was inhibited by a competitive antagonist, eptifibatide.
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We assembled and purified the integrin nanodiscs and charac-
terized them by analytical ultracentrifugation (Table I, Fig. S2, 
A and B) and negative-stain electron microscopy (Fig. 5, B–D). 
The dominant species (77%; molecular weight 299 kD) was 
consistent with a single integrin (Mr 218 k) (Jennings and 
Phillips, 1982) inserted into a nanodisc (Mr 81 k). In nega-
tively stained electron micrographs, we observed a round density 
for the empty nanodiscs, whereas in the integrin nanodiscs we 
observed additional densities (Fig. 5, A–D). Closer examination 
above, there was no gross integrin clustering when THD acti-
vated IIb3 in liposomes (Fig. 1, A and B). To address this 
question definitively, we inserted single integrins into lipid 
while maintaining access to both extracellular and cytoplasmic 
domains by embedding IIb3 into nanodiscs, derived from apo-
lipoprotein A-1 (Denisov et al., 2004). The nanodiscs consist of 
lipid bilayers encircled by membrane scaffold proteins. The inte-
grins are inserted in the lipid bilayer with both extracellular 
and cytoplasmic domain exposed and accessible (Fig. 5 A). 
Table I. Characterization of integrin nanodiscs
Samplea MW MW after subtract empty nanodiscs Integrins per nanodiscs
Empty nanondiscs 80,500 ± 582 D 0 0
Integrin nanodiscs, specie 1 299,000 ± 1,483 D 218,500 1
Integrin nanodiscs, specie 2 530,000 ± 5,451 D 449,500 2
Sampleb Sedimentation coefficient (S*) Areas under S* peak Percentage of total
Nanodiscs, 1 integrin specie 8.56E-13 2.86905 77.4
Nanodiscs, 2 integrin specie 1.47E-12 0.83728 22.6
aMolecular weight measurement of empty nanodiscs, single-integrin nanodiscs and dual-integrin nanodiscs.
bSedimentation coefficient determination of single-integrin nanodiscs and dual-integrin nanodiscs, and their respective percentage in the total population.
Figure 5. Embedding of integrin IIb3 in phospholipid nanodiscs. (A) Model of integrin IIb3 in a compact, bent conformation, inserted into a nano-
disc. The membrane scaffold protein (MSP) is shown in solid surface view, lipid molecules are shown in colored wire, integrins are shown as ribbons. 
The proposed arrangement of the nanodiscs in solution and the likely arrangement of the integrin nanodiscs after drying and flattening in negative stain 
are shown. PDB coordinates for the integrin structures obtained from 3FCS (Zhu et al., 2008) (ectodomain), 2H7E (Wegener et al., 2007) (cytoplasmic 
domain), and 2K9J (Lau et al., 2009) (transmembrane domain). The nanodisc coordinates (Segrest et al., 1999) were obtained from Dr. S.C. Harvey’s web-
site (http://rumour.biology.gatech.edu). (B) Negatively stained EM images of integrin nanodiscs. Several examples of integrin nanodiscs are highlighted 
with red arrows pointing to the nanodisc density and blue arrows pointing to the integrin densities. Bar, 100 nm. (C) Enlarged view of a representative 
gallery of single-integrin nanodiscs shown at higher magnification than in B. Examples of both compact bent-over and extended integrin conformations are 
included. Each panel in C and D is 50 × 50 nm. (D) Similar to C, except that occasional nanodiscs containing two integrins are shown.
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and therefore could not cluster. In others, both integrins faced 
the same way (Fig. 5 D) and were only 10 nm apart; hence, 
they were preclustered (Fig. 5 D). Thus, we have created inte-
grin nanodiscs wherein the integrins are in three states of oligo-
merization: single integrins (the dominant species), and dual 
integrins in which the integrins are either preclustered or ori-
ented in opposing directions.
We captured the IIb3 nanodiscs with an anti-3 antibody 
and assessed their activation state by PAC1 binding (Fig. 6 A, 
top). We reasoned that because integrin nanodiscs are immobi-
lized before addition of THD and ligands, neither THD nor 
ligand can induce further integrin clustering. THD induced a 
of the single-integrin nanodiscs revealed that they assembled 
as depicted (Fig. 5 A) with integrins inserted into the nanodiscs 
and confined to the segregated lipid bilayers of each individual 
nanodisc (Fig. 5 D).
Analytical ultracentrifugation revealed a minor (22.6%; 
Table I) specie of 530-kD mass, indicating an increment of 
449 kD above the empty nanodisc. This increase suggests the 
presence of two integrins per nanodisc. Occasional EM images in 
which two additional densities were associated with the nano-
disc confirmed this suggestion. These densities resembled those 
previously ascribed to integrins and were in two configurations. 
In one, the two integrins were on opposite sides of the nanodisc 
Figure 6. THD activates integrins in nanodiscs. (A) THD increases the binding of PAC1 to captured integrin nanodiscs. The inset shows the configuration of 
the assay, which is described in the Materials and methods section. The activation indices were calculated as (L  L0) / (Lmax  L0) where L = luminescence, 
L0 = luminescence in presence of 1 µM eptifibatide, and Lmax = luminescence in the presence of anti-LIBS6 activating anti-3 antibody. (B) Mutations of THD 
reduce its capacity to activate integrins in nanodiscs. The increase in activation is calculated as in Fig. 3 B. A mutation that reduces membrane binding 
(K322D) or one that blocks binding to the integrin-3 tail (L325R) reduced capacity of THD to activate IIb3 in nanodiscs. (C) EM images of negatively 
stained fibrin and integrin nanodiscs alone. Relatively few integrin nanodiscs are bound to the fibrin. Bar, 100 nm. (D) EM images of negatively stained 
fibrin and integrin nanodiscs in the presence of 5 µM THD showing an increase in the number of bound integrin nanodiscs when THD is present. The top 
insets show enlarged views of integrin nanodiscs bound to the fibrin. Single fibrin-bound integrin nanodiscs are clearly visible, indicating that the increase 
in binding is due to increased monomer affinity rather than clustering. The bottom insets show enlarged views of unbound integrin nanodiscs. Both compact 
and extended conformations are visible. Bar, 100 nm. (E) The local concentrations of nanodiscs were estimated from EM images by manual enumeration 
of nanodiscs/µm2. The number of bound integrin nanodiscs per 10-nm length of fibrin strand was plotted for each concentration. The presence of THD 
increased the number of bound integrin nanodiscs. Error bars = SE (n = 4) for each concentration.
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that the vast majority (89.7%) were in the compact conformation, 
whereas 10.3% of integrin densities appeared to be extended as 
judged by their average height of 19 ± 1 nm. In sharp contrast, 
at least 40% of the fibrin-bound integrins were extended (Fig. 6 D, 
top insets), establishing that this conformer is associated with 
high affinity. When THD was added, 22% of integrins were now 
in the extended conformations in the class-averaged images 
(Fig. 7, C and D; Fig. S4); this result was confirmed by manual 
evaluation of 1,553 images in which there was a marked increase 
in unoccupied integrins in the extended conformation (25%). 
A globular protein the size of THD (5.1 nm; Winkler et al., 
1997) couldn’t be resolved in these negative-stained images. 
Thus, THD induces the extended conformation; hence, this physio-
logically relevant activator can activate and extend integrins in 
the absence of other proteins, ligands, or imposed forces.
In the presence of THD, the compact integrin densities 
appeared slightly less compact than when THD is absent 
(Fig. 7, A and B). We verified this observation by pooling 
images of compact integrins in the presence or absence of 
THD, and subjecting this mixed pool to image analysis of 
alignment and classification. The slightly less compact forms 
were strongly associated with the presence of THD (Fig. 8). 
This result suggests that THD may also induce a more subtle 
difference in conformation.
As noted above, the extended form was more abundant in 
the fibrin-bound integrins. We sought to generate class averages 
of THD-activated, fibrin-bound integrin nanodiscs; however, 
the alignment and class averaging procedure failed because the 
multiple sources of variability from fibrin, integrin, nanodiscs, 
and angle between fibrin and integrins rendered these molecular 
images too heterogeneous to converge. Nevertheless, the raw 
images (Fig. 6 D, top insets) revealed that, at a minimum, 40% 
of these integrins were in extended conformations (extended 
conformation defined as extending more than 15 nm, the mid-
point height between bent-over and extended conformation).
Discussion
Integrin activation is central to metazoan development and 
function, yet there remain sharp divisions of opinion concern-
ing the terminal steps in physiological activation, in large part 
because there were no means to study these events in purified 
systems. Here, we devised two in vitro methods to quantita-
tively study purified integrin activation by THD, a physiologi-
cally relevant activator. We report that THD binding to the 
integrin- tail is sufficient for integrin activation in the absence 
of other proteins; however, efficient talin-induced activation 
requires a membrane-binding site on talin and membrane in-
sertion of the integrin. Furthermore, THD binding can activate 
a kindlin binding–defective integrin mutant, further document-
ing the sufficiency of talin binding for activation. To precisely 
specify the concentrations of proteins accessible to the cyto-
plasmic side of a lipid-inserted integrin while measuring ligand 
binding to the extracellular domain, we embedded integrin 
IIb3 in phospholipid nanodiscs. THD binding activated inte-
grin IIb3 in these nanodiscs, even when the unclustered 
state was both biochemically enforced and documented by EM. 
concentration-dependent increase in PAC1 binding (Fig. 6 A). 
To confirm that the increase in integrin activation is a result of 
physiologically relevant THD–3 interaction, we compared the 
effect of THD, THD(L325R), a mutation that disrupts THD-3 
membrane proximal interaction site, and THD(K322D), a muta-
tion that reduced THD–membrane interaction (Fig. 4 D) 
(Wegener et al., 2007). Both mutations reduced the capacity of 
THD to activate (Fig. 6 B). Thus, THD activates integrin IIb3 
in nanodiscs under conditions which disfavor clustering.
As another test of the idea that THD-induced affinity 
changes do not require clustering, we directly imaged ligand 
binding to THD-activated integrins. We chose fibrin to enable 
visualization of an ordered integrin ligand (Fig. S2 C). When 
integrin nanodiscs were added to the fibrin, we observed few 
fibrin-bound nanodiscs (Fig. 6 C). In sharp contrast, a large 
number of unbound integrin nanodiscs were in the vicinity of 
the fibrin (Fig. 6 C). Addition of THD increased the number of 
integrin nanodiscs bound to the fibrin (Fig. 6 D), providing 
visual confirmation of the activation of the integrins. Moreover, 
this increase in binding was not due to an increase in the local 
concentration of nanodiscs, as the total densities of nanodiscs 
were comparable in the presence and absence of THD (Fig. 6, C 
and D). To quantify THD-induced activation, we measured the 
bound nanodiscs per nm length of fibrin at differing local nano-
disc densities; there was a significant (P = 0.01) increase in the 
number of bound integrin nanodiscs in the presence of THD 
(Fig. 6 F). Discrete nanodiscs containing a single integrin 
(Fig. 6 D, top inserts) were bound to the fibrin. Thus, based on 
biochemical measurements under conditions that prevent clus-
tering and on direct visualization of activated integrins, we con-
clude that the binding of THD induces an increase in the affinity 
of unclustered integrins.
THD induces the extended integrin 
conformation in the absence of ligand or 
externally applied force
To examine the conformational effects of a physiological acti-
vator, talin, on a membrane-embedded integrin, we randomly 
extracted images of 1,283 individual integrin nanodiscs and 
1,553 integrin nanodiscs in the presence of THD and subjected 
them to image analysis of alignment and classification. We set 
number of classes ≈ total images ÷ 50 to capture the variability 
of the integrin nanodiscs and to minimize the possibility of 
grouping different conformations in the same class. The class 
averages of integrin nanodiscs revealed two distinctive confor-
mations (Fig. 7, A–C; Fig. S3). All of the class-averaged integrin 
nanodisc images in the absence of THD revealed a nanodisc 
density and a compact density that averaged a height of 11 ± 1 nm, 
thereby resembling the bent conformation (Takagi et al., 2002; 
Xiong et al., 2002) (Fig. 5 A, Fig. 7 A). Because overrepresented 
images tend to dominate the classes, leaving underrepresented 
images poorly classified (Shaikh et al., 2008) and because 
structural flexibility and heterogeneity can hinder the alignment 
and classification (Penczek et al., 2006; Herman and Kalinowski, 
2008), manual selection of images of different structures are 
frequently warranted (Takagi et al., 2003; Nishida et al., 2006). 
Therefore, we also manually evaluated 1,283 images and observed 
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Figure 7. THD induces the extended conformation in the absence of ligand or externally applied force. All panels are images of 50 × 50-nm fields. The 
number of images in each class is shown at the bottom left corner of each box. (A) Class averages of integrin nanodiscs in compact bent-over conforma-
tion. The class averages show a round-shaped nanodisc density and compact bent-over density for the integrins. All 18 classes are shown in Fig. S3. 
(B) Class averages of integrin nanodiscs in compact conformation in the presence of THD. The class averages show a round-shaped nanodisc density and 
compact density for the integrins. Although the integrin densities are compact, they appear slightly less compact than when THD is absent. The numbers of 
molecular images in each class are shown at the bottom left corner of each box. (C) Class averages of integrin nanodiscs in extended conformation in the 
presence of THD. All classes for the integrin nanodiscs with THD are shown in Fig. S4. (D) Total numbers of extended or compact integrin nanodiscs were 
obtained by summing the number of images in the classes showing extended or compact conformation. Only classes with clearly defined integrin density 
were included in the calculation of the percentages.
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Figure 8. Compact integrin with and without THD roughly segregate into separate classes. Panels are images of 50 × 50-nm fields. Images of nanodiscs 
containing compact integrins from sample prepared in the presence or absence of THD were grouped together, and the pooled images were then classified 
and averaged iteratively. 20 classes were generated during the iterative process (parent classes) and at the final step, each class was split to two subclasses 
(daughter subclasses) to verify the internal consistency of the class averages. Each bracket contains two daughter subclasses from a parent class. Little or 
no difference between the daughter subclasses indicated robust alignment and classification by the iterative procedure. Within each class, the percentage 
of images from samples containing either integrin nanodiscs in the presence or absence of THD are depicted in a pie chart. Each resulting class average 
in which the integrin structure was clearly defined was greatly enriched in images from the integrin nanodiscs alone or from the THD-containing integrin 
nanodisc population. For example, the first row of images shows classes dominated by images from the integrin alone sample (up to 89%). In contrast, the 
second and third row are classes dominated by images from the sample containing added THD (up to 91%). In the classes in which the integrin structure is 
not clearly resolved, both samples were more evenly represented (fourth row). 8 classes of empty nanodiscs were omitted from this figure.
Quantitative analysis of EM images of these nanodiscs revealed 
that talin activation of unoccupied integrins shifted the confor-
mational equilibrium toward extension in the absence of force 
or of other membrane proteins. Thus, we show that talin binding 
alone is sufficient to activate and extend membrane-embedded 
integrin IIb3.
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and activation (Ithychanda et al., 2009). Our data that talin is both 
necessary and sufficient for integrin activation are consistent with 
these hypotheses. These data are also consistent with location of 
the kindlin-binding site on the 3 tail, some distance from the 
membrane proximal site (Wegener et al., 2007) to which talin 
binds to perturbs the inner membrane clasp (Lau et al., 2009) that 
maintains the integrin in the low affinity state.
Talin activation of unoccupied integrins can lead to mo-
lecular extension of single integrins in the absence of force or of 
other membrane proteins. We found that THD activated integrin 
IIb3 in immobilized nanodiscs and identified single-integrin 
nanodiscs bound to ligand, thereby establishing that the indi-
vidual integrins were activated. Previous efforts to resolve this 
issue in cells made use of “monovalent” ligands; however, pro-
tein ligands may still contain multiple subsites. Furthermore, 
mutations that activate integrins may also lead to clustering in 
cells (Hughes et al., 1996); conversely, mutations designed to 
block activation by introducing disulfide bonds (Luo et al., 
2004; Zhu et al., 2007) could also prevent transmembrane do-
main separation and resultant clustering (Li et al., 2003). Within 
cells, full-length talin, having multiple integrin-binding sites 
(Yan et al., 2001), may also cluster integrins as could the bind-
ing of multivalent ligands or the assembly of integrin-associated 
protein complexes. That said, our studies provide the first direct 
proof that THD, a physiologically relevant activator, activates 
demonstrably monomeric integrins.
THD shifts the conformational equilibrium of unoccupied 
integrin toward the extended form. Addition of THD increased 
the abundance of the extended conformation as judged by single-
particle averaging analysis of negative-stained EM images. 
The effect of THD on extension is specific. There is much evi-
dence that the extended conformation is an activated form (Takagi 
et al., 2002; Zhu et al., 2007). Here, we confirm this by showing 
that that more fibrin-bound integrins are in extended conforma-
tion. There is also a general agreement that the low affinity inte-
grins are in a compact conformation (Xiong et al., 2001; Takagi 
et al., 2002). We found that in vitro THD activation requires 
the 3 tail and the integrin- and membrane-binding sites of 
talin, indicating that the effects of THD are specific. Further-
more, this effect of THD is not simply due to presence of re-
combinant protein because 85 µM recombinant membrane 
scaffold protein is present under all conditions; 100-fold 
molar excess relative to the 700-nM EC50 for THD. Extension 
was accompanied by both visual and biochemical evidence of 
activation, thus showing that a biological activator can induce 
extension in the absence of imposed external force. Pioneering 
modeling studies (Puklin-Faucher et al., 2006) suggested that 
such forces could contribute to activation; a prediction subse-
quently verified (Friedland et al., 2009); hence, cellular contractile 
forces may contribute to additional extension and force-induced 
stabilization of adhesion. We note that the conformation of the 
extended integrin observed in nanodiscs differs from soluble 
ectodomains (Takagi et al., 2002). The legs of the extended 
integrins are often crossed rather than separated (Fig. 7 C). 
Future structural assessments will be needed to ascertain whether 
these differences are seen as a consequence of an effect of the 
nanodisc on the orientation of the negative-stained integrin or 
THD activation of integrin IIb3 recapitulates physio-
logical inside-out integrin signal transduction. In two different 
formats (liposomes, nanodiscs) and using three different mea-
sures (PAC1 binding by flow cytometry or ELISA and by visu-
alizing fibrin binding), we found that THD increased the affinity 
of IIb3 for both a model ligand (PAC1) and a physiological 
ligand (fibrin). Previous studies in cells (Calderwood et al., 
1999; Tadokoro et al., 2003) and mice (Petrich et al., 2007a) 
show that THD binding to the  tail is required for activation. In 
the purified system, we found that cleavage of the 3 tail pre-
vented activation as did THD mutations that disrupt either the 
membrane distal (W359A) or membrane proximal (L325R)  
tail binding sites required for activation (García-Alvarez et al., 
2003; Wegener et al., 2007). In the reconstituted liposomes, the 
calculated molar ratio of THD to IIb3 was 2:1. In platelets, 
talin accounts for 3–8% of total proteins in platelet (Collier and 
Wang, 1982). Assuming 1.34 × 1012 g of total protein per 
platelet (Karpatkin and Charmatz, 1970) and 80,000 copies of 
IIb3 (Wagner et al., 1996), the calculated molar ratio of talin 
to IIb3 is 1:1–3:1, similar to the ratio in the reconstituted lipo-
somes. In the integrin nanodiscs, half-maximal IIb3 activa-
tion was observed at a THD concentration of 700 nM, a value 
in remarkable agreement with the 400-nM Kd of talin for inte-
grin IIb3 measured by dynamic light scattering (Goldmann, 
2000). Thus, based on the activation of IIb3 by THD at real-
istic concentrations and the requirement for both the 3 tail and 
for two distinct 3 binding sites on THD, we conclude that we have 
recreated the triggering event in physiological integrin activation.
THD is sufficient to activate integrins in in vitro systems 
and THD can activate a kindlin binding–defective integrin mu-
tant in cells. These results are in good agreement with the weak 
or absent effects of kindlin overexpression when it is not accom-
panied by THD overexpression (Kloeker et al., 2004; Shi et al., 
2007; Ma et al., 2008). In sharp contrast, the genetic deletion of 
kindlins results in deficient integrin activation (Meves et al., 
2009). Kindlin binds to the  tail at a site distinct from the talin-
binding site and the 3(Y759A) mutation disrupts 3–kindlin 
interaction (Ma et al., 2008; Moser et al., 2008). Overexpression of 
the isolated integrin- tails inhibit integrin activation by seques-
tering talin (Calderwood et al., 2004), and mutations in 1 (Zent 
et al., 2000) or 3 (Calderwood et al., 2004) that block talin bind-
ing reverse this process even though these 3 tails retain kindlin 
binding. Kindlins are important in the assembly of focal adhe-
sions (Tu et al., 2003) and in the signaling events that follow inte-
grin ligation (Montanez et al., 2008), and positive feedback from 
integrin ligation can help sustain activation (Shattil and Newman, 
2004). Consequently, kindlins may sustain integrin activation by 
their ability to stabilize integrin-mediated cytoplasmic assem-
blies such as focal adhesions. Alternatively, as previously noted, 
kindlin deficiency may affect cytoskeletal composition, thereby 
affecting talin’s capacity to localize to and activate integrins. 
Filamin can compete with talin for binding to integrins, thereby 
blocking activation (Kiema et al., 2006). Migfilin, a protein re-
cruited by kindlins (Tu et al., 2003), can displace integrins from 
filamin (Lad et al., 2008). These findings were used to advance 
the innovative hypothesis that kindlins recruit migfilin to inte-
grins, thereby displacing filamin to favor talin–integrin interaction 
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due to the release of constraints imposed by the transmembrane 
and cytoplasmic domains in soluble integrin ectodomains (Takagi 
et al., 2002). Previous studies of Mn++ activated integrins (Xiong 
et al., 2002; Ye et al., 2008) reported no extension in Mn2+ acti-
vated integrins, and the present studies are consistent with a 
fraction of THD-activated integrins remaining in a bent, albeit 
subtly altered conformation. THD binds to the integrin cytoplasmic 
face to induce a long-range allosteric rearrangement, whereas 
Mn++ binds to the extracellular integrin A–like domain to in-
duce activation (Shimaoka et al., 2002), and our studies now 
show that talin-induced activation can also lead to molecular 
extension. Finally, a previous structural study (Wegener et al., 
2007) predicted that a talin membrane contact would be re-
quired for integrin activation, a prediction that was supported 
by the observation that joining a membrane-targeting sequence 
to the integrin-binding site of RIAM enables it to both induce 
talin membrane recruitment and integrin activation (Lee et al., 
2009). We now establish that integrin embedding in a phos-
pholipid bilayer is a prerequisite for talin-induced activation. 
Notably, the PH domain of kindlin-2 is required for its capacity 
to induce integrin activation, hinting that kindlins might also 
require membrane binding to influence integrins (Ma et al., 2008). 
Our establishment of this tractable system for analysis of the 
functions and structure of lipid-embedded integrins will en-
able a detailed examination of the role of membrane lipids in 
integrin function.
Integrin activation is of broad biological relevance and it 
represents a reversal of the direction of transmembrane signal-
ing from the inside out (Hynes, 2002). Recent advances include 
high resolution crystal structures of integrin ectodomains (Xiong 
et al., 2001, 2002; Zhu et al., 2008), NMR structures of the 
heterodimeric transmembrane domains (Lau et al., 2009), and 
identification of critical cytoplasmic players in the final events 
of the activation process (Tadokoro et al., 2003; Han et al., 2006; 
Moser et al., 2009b) and the structures of some of them in com-
plex with integrin tails (García-Alvarez et al., 2003; Wegener et al., 
2007). The present study represents the next, critical step in our 
understanding of this process: the recreation of the last events in 
physiological inside-out integrin signaling. By resolving on-
going controversies about the sufficiency of talin for activation, 
the role of the membrane, and the extension of talin-activated 
unoccupied integrins, we set the stage for future studies to ana-
lyze these structural transitions, to examine the regulation of the 
process by other purified proteins or by changes in membrane 
lipid composition, and ultimately for the complete in vitro assem-
bly of focal adhesions.
Materials and methods
Antibodies
The conformation-specific monoclonal antibody PAC1 (Shattil et al., 1985), 
monoclonal anti-3 antibody AP3 (Newman et al., 1985), and rabbit 
polyclonal antibodies against whole-3 (Ab8053), against IIb-c tail 
(Ab8276), and against 3-c tail (Ab8275) have been described previously 
(Du et al., 1995).
Purification of inactive integrin IIb3
Integrin IIb3 was purified from outdated human platelets based on a 
modified protocol from Ye et al. (2008). In brief, outdated platelets were 
spun down first at 300 g to remove the red blood cells and leucocytes and 
subsequently at 1,800 g to pellet the platelets. The platelets were washed 
twice with Tris-buffered saline and then extracted overnight with lysis buf-
fer: 20 mM Tris, pH 7.4, 150 mM NaCl, 1% Triton X-100, 5 mM PMSF, 
0.5 mM CaCl2, 10 µM leupeptin, 10 µM protease inhibitor E64 (Sigma-
Aldrich), and 2.76 µM calpeptin. The extracted integrin IIb3 was first 
purified with a Con A column, and then passed through a heparin column 
to remove fibrinogen and thrombospondin 1. IIb3 was further purified 
by gel filtration chromatography and the inactive fraction was isolated as 
the flow-through of an immobilized KYGRGDS affinity matrix as described 
by Kouns et al. (1992). The final purified integrins are in a buffer of 20 mM 
Tris, pH 7.4, 150 mM NaCl, 0.1% Triton X-100, 1 mM MgCl2, and 1 mM 
CaCl2. The pure inactive integrin was subjected to an integrin activity assay 
described below, performed to verify the inactive status of the integrins 
(Fig. S5). The abundance of contaminating fibrinogen was <5% and of 
kindlin-3 was <2% of that of the purified integrin based on the densitometry 
of the Coomassie blue staining of SDS-PAGE (Fig. S5).
Purification of recombinant talin head
The recombinant human talin head expression plasmid construct was ob-
tained from Dr. Steve Lam (Patil et al., 1999). This construct, which contains 
amino acids 1–465 of human talin1, was truncated at residue 433 by in-
troduction of a stop codon, and a his6 tag was added to the C terminus to 
facilitate purification. Mutations within the talin head were introduced with 
the QuikChange Mutagenesis kit (Stratagene). The wild-type and mutant 
proteins were expressed in Escherichia coli BL21-DE-pLys (which produced 
higher protein yields) and purified with His-binding beads according to the 
manufacturer’s instructions (EMD). The purified proteins were first dialyzed 
against 20 mM Tris, 150 mM NaCl, pH 7.4 (TBS buffer) with 2 mM EDTA 
to completely remove the residual Ni2+ on the his6 tag, which caused lipid 
precipitation problems, and then against EDTA-free TBS buffer.
Liposome reconstitution and purification
Integrin–talin head liposomes were made with a protocol modified from Ye 
et al. (2008). In brief, 450 nmol 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
(DMPC), 450 nmol 1,2-dimyristoyl-sn-glycero-3-phospho-(1’-rac-glycerol) 
(DMPG), and 200 nmol cholesterol were solubilized in chloroform or a 
chloroform/methanol mixture, mixed thoroughly, and dried onto a glass 
tube under steady flow of nitrogen. The homogeneous lipid mixture was 
then solubilized with 20 mM Tris, 150 mM NaCl, pH 7.4, 0.1% Triton X-100, 
and 1 mM -mercaptoethanol. 0.2 mg of IIb3 with or without 0.5 mg 
of talin head construct in the same buffer was added to the lipid solution. 
The final volume of the entire mixture was 1 ml. To induce liposome forma-
tion, Triton X-100 in the solution was removed by several additions (in 3-h 
intervals) of 85 mg SM-2 Biobeads prewashed with methanol and water 
until the solution became visibly cloudy. The reconstituted liposomes were 
purified on a sucrose gradient to separate the free proteins from the recon-
stituted protein-liposome. The visible liposome band was extracted and dia-
lyzed against three changes of 20 mM Tris and 150 mM NaCl, pH 7.4. 
Successful incorporations of talin head and integrins were verified by 
SDS-PAGE and Cryo-EM tomography.
Recombinant talin F3 expression and liposome cosedimentation assay
Talin F3 and F3(K322D) were expressed and purified as described previ-
ously (Wegener et al., 2007). In brief, GST-F3 or GST-F3(K322D) was ex-
pressed with pGEX-6P vector and purified with glutathione-conjugated 
agarose beads. F3 or F3(K322D) was then cleaved off from the GST using 
PreScission protease (GE Healthcare), and further purified with a Superdex 
200 size exclusion column. The molecular weights of purified F3 or F3 mutant 
measured by matrix-assisted laser desorption mass spectrometry varied by 
less than 0.1% from calculated values. For the liposome cosedimentation 
assay, liposomes were prepared as described above except that no integrins 
were incorporated. 1 ml of 5 µg/ml purified F3 or F3 (K322D) was incu-
bated with 100 µl of liposomes at room temperature for 1 h. The liposomes 
were centrifuged at 14,000 rpm for 30 min. The liposome pellets were 
washed and solubilized with 1× SDS-PAGE loading buffer and analyzed by 
SDS-PAGE. Coomassie-stained protein bands were scanned and quantified 
using an infrared fluorescence spectrometer (LI-COR Biosciences).
Liposome integrin activity assays
PAC1 binding was measured by fluorescence-activated cell sorting (FACS). 
For the analysis, 9 µl of purified liposomes were mixed with 6 µl of 25 µg/ml 
FITC-conjugated PAC1. After incubation for 30 min, the sample was diluted 
into 150 µl 20 mM Hepes and 150 mM NaCl, pH 7.4 (HBS buffer) and ana-
lyzed using FACSCalibur (BD). For each sample, separate FACS analysis was 
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The homogeneous lipid mixture was then solubilized in 100 mM cholate 
in 10 mM Tris and 100 mM NaCl, pH 7.4, giving a lipid concentration of 
50 mM. 72 µl of the lipid solution was then mixed with 200 µl of 200 µM 
membrane scaffold protein (MSP) in dH2O and 200 µl of 10 µM purified 
inactive integrin (described earlier). The final ratio of lipids/MSP/protein 
is 90:1:0.05 in a total volume of 472 µl. The integrin nanodiscs were 
assembled by removing the detergents with SM-2 Biobeads overnight at 
room temperature. The assembled integrin nanodiscs were then purified 
with a hi-load 16/60 Superdex 200 size exclusion column with 20 mM 
Tris, 150 mM NaCl, and 0.5 mM CaCl2, pH 7.4, as the column buffer. The 
integrin nanodiscs and empty nanodiscs were readily separated (Fig. S2) 
and the successful assembly was verified by SDS-PAGE analysis. Two MSP 
constructs, MSP1D1 and MSP1E3D1 (Denisov et al., 2004) expressed and 
purified from bacteria, were used to make integrin nanodiscs and similar 
patterns of integrin activation results were obtained with both constructs.
Analytical ultracentrifugation
Analytical ultracentrifugation was performed with a ProteomeLab (model 
XL-I) centrifuge according to the instructions from Beckman Coulter and 
established theories (Lebowitz et al., 2002). In brief, the integrin nanodiscs 
and empty nanodiscs were prepared and concentrated to 1 mg/ml using a 
Centricon concentrator with a molecular cut-off of 3 kD. For sedimentation 
equilibrium experiments, samples were analyzed in triplicate in three centri-
fuge chambers at different dilutions. The distributions of protein along the 
centrifugation force were determined by UV absorption at 280 nm. The 
measured protein distribution curves were then fitted to a theoretical model 
to determine the molecular weight. Buffer density calculated based on buffer 
composition and average protein partial specific volume was used as a pa-
rameter for the curve fitting. The molecular weight standard deviations were 
calculated from triplicates and the curve fitting residuals. The empty nano-
discs were analyzed at the centrifuge speed of 13,000 rpm. The integrin 
nanodiscs were first analyzed at a centrifuge speed of 5,000 rpm. We ob-
served a high base absorption (the lowest 280-nm absorption at the start of 
the curve is 0.35 at 5,000 rpm; Fig. S2 B) and a persistent and high fitting 
residual, suggesting the presence of a second, lighter component in the so-
lution. Therefore, we repeated the experiments to measure the lighter com-
ponent at 10,000 rpm, at which the 530-kD component was calculated to 
be mostly at the bottom third of the centrifuge chamber and would not inter-
fere with the measurement of the lighter component. For sedimentation ve-
locity experiments, the samples were centrifuged at 20,000 rpm and the 
sedimentation coefficient curves were determined according to Beckman 
Coulter. The curves were then fitted to determine the sedimentation coeffi-
cient of each component in the solution and their ratios.
Integrin nanodisc activation assay
Integrin nanodisc activation assays were performed in a similar manner to 
that used to study the detergent-solubilized integrin as described above. In 
brief, ELISA plates were coated with 5 µg/ml AP3 antibody overnight at 
4°C, blocked with BSA for 1 h at 37°C. After washing the plate, integrin 
nanodiscs were added to the plate. The plate was incubated for 3 h at 
room temperature. The integrin nanodiscs were then activated by various 
concentrations of THD as indicated, and activation was detected by bind-
ing of PAC1 antibody. PAC1 binding in the presence of anti-LIBS6 antibody 
was used as control for full activation and PAC1 binding in the presence of 
20 µM eptifibatide was used as negative control. After 3 h of incubation, 
the wells were again washed and HRP-conjugated anti–mouse IgM (for 
PAC1 wells) was added for 1 more hour of incubation. After the final wash, 
ECL reagent was added to the wells and the luminescence of each well 
was read on a Victor2 plate reader. The activation indices were calculated 
as 100 × (L  L0) / (Lmax  L0), where L = luminescence intensity, L0 = 
luminescence in presence of 1 µM eptifibatide, and Lmax = luminescence in 
the presence of anti-LIBS6 antibody. Increase in activation was calculated as 
AIwith-THD  AIintegrin-alone, where AI stands for activation indices.
Integrin nanodiscs binding to fibrin and negatively stained EM images of 
integrin nanodiscs
2D fibrin was prepared by lipid monolayer technique as described previ-
ously (Taylor and Taylor, 1999; Taylor et al., 2007). In brief, wells in a Tef-
lon block were filled with a fibrinogen solution. Thrombin was added to 
each well and a positively charged lipid solution was immediately applied 
to the solution surface to form the lipid monolayer. The samples were incu-
bated at room temperature for 1 h while fibrin polymerized, and were then 
stored at 4°C. The fibrin was imaged to verify its 2D integrity and appropri-
ate concentration. To test their binding to fibrin, the integrin nanodiscs 
were first incubated (with a THD concentration of either 0 or 5 µM) for 2 h 
performed with addition of 1 mM MnCl2 as a control for full activation and 
MnCl2 plus 20 µM eptifibatide as a negative control. Because larger lipo-
somes would have more integrin incorporated and thus exhibit higher PAC1 
binding, we plotted PAC1 binding against liposome size using forward scat-
tering (FSC) as a size measurement. This plot helped us compare the PAC1 
binding of liposomes with the same size. The PAC1-FSC plots were further 
analyzed by dividing the liposomes into 11 subsets along the FSC axis. 
The mean FSC and mean fluorescent intensity (MFI) of PAC1 binding was 
calculated for each subset. The activation indexes were calculated as 100 × 
(F  F0) / (Fmax  F0), where F = PAC1 binding, F0 = binding in the presence 
of 20 µM eptifibatide, and Fmax = binding in the presence of 1 mM MnCl2. 
The PAC1 MFI or the activation index was then plotted against the FSC.
Assaying the effect of THD in CHO cells stably expressing IIb3
Using a lentiviral cloning vector pRRLSIN.cPPT.PGK-IRES-GFP.WPRE. (Add-
gene, plasmid ID 12252), viruses containing IIb or 3 gene were gener-
ated separately as described previously (Wiznerowicz and Trono, 2003). 
CHO cells stably expressing integrin IIb3 were established by co-infection 
of CHO K1 cells with the IIb and 3 viruses. The Y747A and Y759A muta-
tions were introduced into the 3 gene with the QuikChange Mutagenesis kit. 
To assess the effects of THD on the activation of integrins, 3 µg THD expres-
sion construct and 0.1 µg D-tomato (a transfection marker) was cotransfected. 
After 24 h, the cells were trypsinized, stained with PAC1 for 30 min, washed, 
stained with APC-conjugated anti–mouse IgM, and then analyzed by FACS. 
Separate FACS was also performed in the presence of anti-LIBS6 as full acti-
vation control and in presence 20 µM eptifibatide as negative control. To as-
sess the effect of kindlin-2 on those cells, 3 µg THD expression construct, 
0.5 µg of kindlin-2 construct, and 0.1 µg D-tomato construct were cotrans-
fected into the cells, and the cells were stained as described above and ana-
lyzed by FACS.
Assay for calpain cleavage
To cleave 3 tail from the purified IIb3, 25 µl of 1 mg/ml recombinant 
calpain-II (EMD) was added to 500 µl of 2 mg/ml purified IIb3 in a buffer 
of TBS plus 0.1% Triton X-100, 1 mM CaCl2, and 1 mM MgCl2. The mixture 
was incubated at room temperature overnight. The next morning, the calpain 
was neutralized by adding protease inhibitor E-64 (Sigma-Aldrich) at a final 
concentration of 10 µM plus calpain inhibitor calpeptin at a final concentra-
tion of 5 µM. An ELISA assay was developed to measure the effectiveness of 
the cleavage. In brief, ELISA plates were coated with 5 µg/ml AP3 antibody 
overnight at 4°C, blocked with BSA for 1 h at 37°C, and incubated with 
6 µg/ml of cleaved or uncleaved IIb3 for 1 h at room temperature. After re-
moving the protein solution and washing the ELISA plates, either Ab8053 
against the whole protein, Ab8276 against the IIb, or Ab8275 against 
the 3 tail were added to the captured IIb3. After 1 h of incubation, the 
unbound antibodies were removed, the wells were washed again, and horse-
radish peroxidase (HRP)–conjugated goat anti–rabbit Ig antibodies were 
added for another hour of room temperature incubation. The amount 
of antibody binding was measured using enhanced chemiluminescence 
(ECL) reagent as peroxidase substrate (BD) and read on a Victor2 plate 
reader (PerkinElmer).
Integrin activity assay
For the integrin activity assay, ELISA plates were coated with 5 µg/ml AP3 
antibody overnight at 4°C, blocked with BSA for 1 h at 37°C. After wash-
ing the plate, 6 µg/ml integrin with different amounts of talin head were 
added on to the plate. The plate was incubated for 2.5 h at room tempera-
ture. The wells were then washed and detected with either PAC1 antibody 
to measure the activity or anti-3 Ab8053 to measure the capture. 1 mM 
MnCl2 and 1 mM MnCl2 plus 20 µM eptifibatide were used as positive and 
negative controls. After 1 h of incubation, the wells were again washed 
and HRP-conjugated anti–mouse IgM (for PAC1 wells) or HRP-conjugated 
anti–rabbit Igs (for Ab8053 wells) were added for 1 more hour of incuba-
tion. After the final wash, ECL reagent was added to the wells and the plate 
was read on a Victor2 plate reader (PerkinElmer). The procedure for the 
alternative activity assay configuration was similar to that described above, 
except that the plates were coated with 25 µg/ml of PAC1 antibody and 
that anti-3 Ab8053 followed by HRP-conjugated anti–rabbit antibody 
was used to detect the amount of bound integrin.
Integrin nanodiscs assembly and purification
Integrin nanodiscs were assembled based on a protocol adapted from pre-
vious papers (Denisov et al., 2004; Nath et al., 2007). In brief, DMPC and 
DMPG were solubilized in chloroform or a chloroform/methanol mixture, 
mixed thoroughly, and dried onto a glass tube under steady flow of nitrogen. 
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then injected into the fibrin sample well where the final buffer concentration 
was 20 mM Tris, 50 mM NaCl, and 0.2 mM CalCl2, pH 7.6, and incu-
bated for 24 h at 4°C. The resulting lipid monolayer sample was lifted on 
a reticulated carbon film and stained with 2% uranyl acetate. Images of the 
fibrin with integrin nanodiscs were taken on a transmission electron micro-
scope (model 1200EX; JEOL) at a magnification of 65,000. The images 
were recorded on Kodak film and were digitized with a film scanner 
(Coolscan 9000; Nikon) to give a final pixel size of 3.9Å. The numbers of 
bound integrin nanodiscs and of unbound integrin nanodiscs were counted 
manually. The length of the fibrin was measured in ImageJ by tracing the 
fibrin fiber with segmented line.
Cryoelectron tomography
Specimens were prepared on glow-discharged, 200-mesh copper grids with 
reticulated carbon support film with a 2-µm hole size (Quantifoil, Inc.). The 
grids were plunge-frozen in liquid ethane and examined at a temperature of 
180°C. The data were collected at a magnification of 24,000 on an elec-
tron microscope (model CM300-FEG; FEI) (integrin liposomes) and at a mag-
nification of 31,000 on an electron microscope (Polara; FEI) (integrin + THD 
liposomes), each equipped with a 4 × 4-k CCD camera. The tomography tilt 
series was collected at an underfocus of 6–8 µm. The tilt range covered 
65° to 65° with Saxton scheme angle increments with an initial angle of 
2.0° and 1.5°, respectively (Saxton et al., 1984). The raw tilt images were 
processed and aligned with a marker-free alignment algorithm and the 3D 
reconstruction was calculated by weighted back projection (Winkler and 
Taylor, 2006).
Particle selection and 2D averaging
All images processing were performed with the EMAN1.9 package (Ludtke 
et al., 1999). Integrin nanodisc molecular images were identified in images. 
Images of well-resolved integrin nanodiscs not bound to fibrin were used 
for further image processing. In total, we obtained 1,283 images for integrin 
nanodiscs alone and 1,553 images for integrin nanodiscs in the presence 
of THD. The extracted molecular images were normalized, contrast transfer 
function (CTF) corrected by phase flipping, and low-pass filtered to 10Å 
resolution. The images were then subjected to an iterative classification, 
alignment, and averaging algorithm. No initial model or references were 
used and the data robustly converged to a final set of class averages. Mini-
mum number of particles per class was set to be 20. Typical command 
used for 2D average and classification is: “refine2d.py–iter=41–ninitcls= 
10–finalsep=2–nbasis=64–minptcl=20”. The integrin nanodiscs activated 
by THD separated into class averages of either compact or extended con-
formations. However, due to the smaller number and the lower percentage 
of extended conformation in the sample of integrin nanodiscs alone, the 
algorithm failed to generate any classes attributable to the extended confor-
mation despite repeated efforts with various parameter settings. The total 
numbers of extended or compact integrin nanodiscs were obtained by 
summing the number of images in the classes showing extended or com-
pact conformation. The class averages showing only nanodisc density were 
treated as contaminating empty nanodiscs and their numbers were not in-
cluded the activity calculation.
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